Compare COX & KINGS with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

COX & KINGS vs INDOCO REMEDIES - Comparison Results

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    COX & KINGS INDOCO REMEDIES COX & KINGS/
INDOCO REMEDIES
 
P/E (TTM) x 0.0 116.6 0.0% View Chart
P/BV x 0.0 2.0 0.7% View Chart
Dividend Yield % 44.6 0.7 6,415.2%  

Financials

 COX & KINGS   INDOCO REMEDIES
EQUITY SHARE DATA
    COX & KINGS
Mar-17
INDOCO REMEDIES
Mar-18
COX & KINGS/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs242317 76.2%   
Low Rs146178 82.1%   
Sales per share (Unadj.) Rs406.2113.1 359.3%  
Earnings per share (Unadj.) Rs12.04.5 268.4%  
Cash flow per share (Unadj.) Rs17.411.8 147.1%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Dividend yield (eoy) %0.50.4 127.6%  
Book value per share (Unadj.) Rs147.273.2 200.9%  
Shares outstanding (eoy) m176.6592.15 191.7%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x0.52.2 21.8%   
Avg P/E ratio x16.255.5 29.2%  
P/CF ratio (eoy) x11.221.0 53.2%  
Price / Book Value ratio x1.33.4 39.0%  
Dividend payout %8.322.4 37.3%   
Avg Mkt Cap Rs m34,28822,830 150.2%   
No. of employees `000NA5.5 0.0%   
Total wages/salary Rs m7,4552,209 337.5%   
Avg. sales/employee Rs ThNM1,910.1-  
Avg. wages/employee Rs ThNM405.0-  
Avg. net profit/employee Rs ThNM75.5-  
INCOME DATA
Net Sales Rs m71,76210,419 688.7%  
Other income Rs m46547 990.4%   
Total revenues Rs m72,22710,466 690.1%   
Gross profit Rs m6,8091,349 504.6%  
Depreciation Rs m953677 140.8%   
Interest Rs m2,255235 959.2%   
Profit before tax Rs m4,065484 839.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-1170-   
Extraordinary Inc (Exp) Rs m-1090-   
Tax Rs m1,72272 2,378.9%   
Profit after tax Rs m2,117412 514.4%  
Gross profit margin %9.512.9 73.3%  
Effective tax rate %42.415.0 283.2%   
Net profit margin %3.04.0 74.7%  
BALANCE SHEET DATA
Current assets Rs m46,8045,373 871.1%   
Current liabilities Rs m30,2974,157 728.8%   
Net working cap to sales %23.011.7 197.1%  
Current ratio x1.51.3 119.5%  
Inventory Days Days168 1.5%  
Debtors Days Days9373 127.2%  
Net fixed assets Rs m42,0896,244 674.1%   
Share capital Rs m883184 479.0%   
"Free" reserves Rs m25,1126,566 382.5%   
Net worth Rs m25,9956,750 385.1%   
Long term debt Rs m25,5991,233 2,076.5%   
Total assets Rs m89,97012,363 727.8%  
Interest coverage x2.83.1 91.6%   
Debt to equity ratio x1.00.2 539.2%  
Sales to assets ratio x0.80.8 94.6%   
Return on assets %4.95.2 92.9%  
Return on equity %8.16.1 133.6%  
Return on capital %11.89.0 131.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,6023,762 42.6%   
Fx outflow Rs m831,143 7.3%   
Net fx Rs m1,5192,619 58.0%   
CASH FLOW
From Operations Rs m2,6271,227 214.0%  
From Investments Rs m-233-1,360 17.1%  
From Financial Activity Rs m-2,600-388 670.5%  
Net Cashflow Rs m-206-521 39.5%  

Share Holding

Indian Promoters % 32.0 59.2 54.0%  
Foreign collaborators % 16.0 0.0 -  
Indian inst/Mut Fund % 5.4 12.5 43.0%  
FIIs % 33.9 6.0 565.5%  
ADR/GDR % 0.2 0.0 -  
Free float % 12.5 22.4 55.8%  
Shareholders   28,340 12,805 221.3%  
Pledged promoter(s) holding % 43.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare COX & KINGS With:   MOTILAL OSWAL  FINOLEX INDUSTRIES  BAJAJ FINANCE  STC INDIA  TIL  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

COX & KINGS Announces Quarterly Results (4QFY19); Net Profit Up 6694.7% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, COX & KINGS has posted a net profit of Rs 14 bn (up 6694.7% YoY). Sales on the other hand came in at Rs 13 bn (down 21.0% YoY). Read on for a complete analysis of COX & KINGS's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

COX & KINGS SHARE PRICE


Oct 17, 2019 03:37 PM

TRACK COX & KINGS

  • Track your investment in COX & KINGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COX & KINGS 8-QTR ANALYSIS

COMPARE COX & KINGS WITH

MARKET STATS